Justin Hirsch
@Octagon Capital Advisors Lp
Latest period2024 - Q3ReportedManaged Assets$642.902MTotal holdings41
Assets growth rate1.05%Assets growth rate (2-Q avg)-11.35%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Octagon Capital Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.
Assets under management
The assets under management (AUM) of Octagon Capital Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 642.902M in assets, with a quarterly growth rate of 1.05% and a 2-quarter average growth rate of -11.35%. The portfolio is managed by Justin Hirsch, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GPCRStructure Therapeutics Inc
| 8.18% | $52.58M 1.198M shares@ $43.89 avg price | Increased 5.09% |
AVBPArrivent Biopharma Inc
| 7.23% | $46.445M 1.976M shares@ $23.51 avg price | Increased 9.6% |
NUVBNuvation Bio Inc
| 4.34% | $27.873M 12.172M shares@ $2.3 avg price | Increased 2720.1% |
CRBPCorbus Pharmaceuticals Hldgs
| 3.58% | $23.002M 1.115M shares@ $20.63 avg price | Increased 128.49% |
VRDNViridian Therapeutics Inc
| 3.08% | $19.793M 870,000 shares@ $22.75 avg price | Increased 40.33% |
MNMDMind Medicine Mindmed Inc
| 2.68% | $17.172M 3.018M shares@ $5.69 avg price | Increased 40.18% |
ALVRAllovir Inc
| 1.41% | $9.057M 11.202M shares@ $0.81 avg price | Increased 14.31% |